ArticleACS applied polymer materials2025
Poly (hydroxyethyl methacrylate) Saliva-Gel: A Polymer-Based Solution for Xerostomia Treatment.
Article in ACS applied polymer materials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Dry mouth (xerostomia) often leads to difficulties in swallowing, speaking, and maintaining good oral hygiene. Present therapeutic interventions for xerostomia yield temporary symptom alleviation or are invasive. In this study, we employ the biocompatible polymer, poly(hydroxyethyl methacrylate) (PHEMA), to create a PHEMA-based saliva-gel to regulate the release of artificial saliva and emulate the properties of natural salivary secretion as a non-invasive dry mouth treatment mechanism. The saliva-gel exhibited a swelling capacity of approximately 400% of its original volume within 6 h. The high swelling capacity of the saliva-gel allows it to absorb and retain a significant amount of saliva, effectively increasing the amount of oral saliva and potentially providing sustained relief from dryness. The optimized saliva-gel exhibited a release rate of nearly all its stored artificial saliva within 4 h at body temperature and exhibited a 97% efficiency in its release properties, which remained consistent through five continuous cycles. It also demonstrated reusable absorbance properties for these five cycles. The release rate of the saliva-gel, aligns with the goal of providing timely relief for dry mouth symptoms. These findings collectively suggest that the study successfully demonstrates the potential of these materials for the treatment of xerostomia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.